ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2015

Combinatorial immunotherapy of sorafenib and blockade of programmed death-ligand 1 induces effective natural killer cell responses against hepatocellular carcinoma.

Yun Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.